Navigation Links
Pharmacopeia to Present at The Roth 20th Annual OC Growth Stock Conference
Date:2/13/2008

PRINCETON, N.J., Feb. 13 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced that Dr. Leslie J. Browne, President and Chief Executive Officer, will deliver a corporate presentation at the Roth 20th Annual OC Growth Stock Conference. The conference will be held February 18-21, 2008, at The Ritz Carlton Laguna Niguel in Dana Point, CA.

Dr. Browne's presentation will take place at 10:30 a.m. local time on Thursday, February 21st. The presentation will include an overview of the company's drug development pipeline, including an update on its internal clinical programs, PS433540 (DARA), which is progressing in Phase 2, and PS178990 (SARM), which is currently in Phase 1. A live webcast and 90-day archive of the presentation can be accessed at http://www.pharmacopeia.com.

ABOUT PHARMACOPEIA

Pharmacopeia is a clinical development stage biopharmaceutical company dedicated to discovering and developing novel small molecule therapeutics to address significant medical needs. The company has a broad portfolio of clinical and preclinical candidates under development internally or by partners including seven clinical compounds in Phase 2 or Phase 1 development addressing multiple indications including hypertension, diabetic nephropathy, muscle wasting, inflammation and respiratory disease. The company is leveraging its fully integrated drug discovery platform to sustain the growth of its development pipeline. Pharmacopeia has established strategic agreements with major pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, Celgene, Cephalon, GlaxoSmithKlin
'/>"/>

SOURCE Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. USP publishes Spanish edition of United States Pharmacopeia and National Formulary
2. USP Publishes Spanish Edition of United States Pharmacopeia and National Formulary
3. U.S. Pharmacopeia 8th Annual MEDMARX(R) Report Indicates Look-Alike/Sound-Alike Drugs Lead to Thousands of Medication Errors Nationwide
4. US Pharmacopeia partners with Quantros to enhance the MEDMARX patient safety reporting program
5. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
6. Pharmacopeia Acquires Selective Androgen Receptor Modulator (SARM) Program from Bristol-Myers Squibb
7. Pharmacopeia Announces Senior Additions to Management Team
8. Pet DRx to Present at Roth 20th Annual OC Growth Stock Conference
9. AtriCure to Present at Roth Capital Partners 20th Annual OC Conference
10. Gen-Probe to Webcast Presentation at Deutsche Bank Small- and Mid-Cap Growth Conference
11. Inexpensive Online Pain Education Program for Physicians as Effective as Live Presentations by National Experts

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , CLEVELAND, Ohio, November 30 /PRNews...ading developer of medical simulation systems, in ...ffering a PROcedure Rehearsal Studio(TM),workshop ... Frankfurt,Germany. , The Simbionix PROc...dical,simulator to enable clinicians to create pra...
(Date:11/30/2009)...ICAGO Three decades ago, a study revealed that be...ren, prompting a switch by U.S. manufacturers to s...l meeting of the Radiological Society of North Ame...ntially unsafe. , "One of the driving factors le...he U.S. was to eliminate inadvertent swallowing of...
(Date:11/30/2009)...DALLAS Nov. 30, 2009 UT Southwestern Medical Cen...n help families stave off complications associated...n the December issue of Pediatrics, suggest that...thmatic children who have received specialized top...thma attacks, emergency room visits and missed adu...
(Date:11/29/2009)... , ATLANTA, Nov. 29 The foll...ntellivest Securities Research, Inc. ,, Intelli...registered investment advisor, has published a Rep...nies in the pharmaceutical, biotechnology and medi...ng their clients manage, process and submit medica...
(Date:11/29/2009)...SANTA CRUZ, CA--New connections begin to form betw...n a new task, according to a study published this ...sity of California, Santa Cruz, the study involved...hat take place in the brain during motor learning....ined to reach through a slot to get a seed. They o...
Breaking Medicine News(10 mins):Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 3Health News:Beverage can stay-tabs pose swallowing risk 2Health News:Parent mentors can improve the asthmatic care of minority children, UT Southwestern researchers find 2Health News:Research Report on BioClinica, Inc. as Speculative Buy 2Health News:Study shows new brain connections form rapidly during motor learning 2Health News:Study shows new brain connections form rapidly during motor learning 3
...orum AmericaSpeakOn.org issued the following e...es as a pandemic level event," said former Health ...t will be five months before a safe vaccine is rea...nt is available at AmericaSpeakOn.org . , , ...
...ions Foundation announced today that, working with...346,000 life-saving bed nets to refugees in tempor... Washington, D.C. (Vocus) April 27, 200...to refugees in temporary camps in 11 African count...
...izenship Priorities: Innovating for the Future, En...rotecting Patients and Consumers , , ABBOTT PAR...ase of its 2008 Global Citizenship Report entitled...people,s lives around the world, focused on four k...
...s Featured In Film And Local Alzheimer,s Caregiver... The community is invited to attend a FREE advanc...BO Documentary Films, THE ALZHEIMER,S, ...r, Anne Sandkuhler, will be featured g...
...(NYSE: NTY ) ( www.NBTY.com ), a leading globa...ents, today announced that it will web cast the pr...nancial Officer of NBTY, at the Barclays Capital...y Web site, www.nbty.com , on Wednesday, April ...
...irmed cases of swine flu in Mexico, Canada, and th...re advising against travel to North America. At a..., thermal scanners are being used to identify feve...evere acute respiratory syndrome) in 2003 teaches ...
Other Medicine News:Health News:AmericaSpeakOn.org Exclusive: Leavitt Asks 'How Prepared Is the US for the Swine Flu Pandemic?' 2Health News:UN Foundation to Help Protect More than a Million Refugees from Malaria in Africa 2Health News:Abbott Highlights Strong Corporate Responsibility Performance With Release of 2008 Global Citizenship Report 2Health News:Abbott Highlights Strong Corporate Responsibility Performance With Release of 2008 Global Citizenship Report 3Health News:HBO, Warner Bros. Employee Initiatives and the Alzheimer's Association, California Southland Chapter Present a Free, Public, Advance Screening of THE ALZHEIMER'S PROJECT: 'Caregivers' 2Health News:NBTY to Webcast Presentation at Barclays Capital 2009 Retail And Restaurants Conference 2Health News:NBTY to Webcast Presentation at Barclays Capital 2009 Retail And Restaurants Conference 3Health News:Swine Flu: Infection Control in Hospitals Will Be Critical 2
(Date:11/27/2009)...MINGTON, Minn, Nov. 27 ACUO TECHNO...ge management software, data migration tools and s...ates Patent and Trademark Office has approved a pa...t within a Computer Network." Acuo Technologies is...f intellectual property. In general, the granted p...
(Date:11/25/2009)...LOVELAND, Colo., Nov. 25 ...rovider of advanced diagnostic and specialty pro...agreements with Roche Diagnostics Corporation for ...nsumables for the veterinary market. ,, (Log...HESKALOGO ) ,, "Heska and Roche share the same ...
(Date:11/25/2009)...TON, Pa., Nov. 25 BioTrends Resear...ds(TM) : Stelara report, the first in a multi... the launch of Centocor Ortho-Biotech,s Stelara, f... availability. Each wave of the report provides q...sts and qualitative information from a subset of 2...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2CEL SCI to Conduct First Clinical Study of Investigational LEAPS H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University Sc 60824 1CEL SCI to Conduct First Clinical Study of Investigational LEAPS H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University Sc 60824 2CEL SCI to Conduct First Clinical Study of Investigational LEAPS H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University Sc 60824 3Intarcia Therapeutics Inc Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes T 14748 1Intarcia Therapeutics Inc Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes T 14748 2Intarcia Therapeutics Inc Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes T 14748 3Intarcia Therapeutics Inc Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes T 14748 4Intarcia Therapeutics Inc Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes T 14748 5OTCBB VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 6051 1OTCBB VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 6051 2OTCBB VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 6051 3OTCBB VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 6051 4
...alin(R) First-Line Indolent (FIT) Phase III Clinic...l of Clinical Oncology, SEATTLE, Oct. 16 Cell Th...unced today that the Journal of Clinical,Oncology ...nt Trial (FIT),demonstrating that use of Zevalin(R...rapy after remission induction in previously untre...
...earchers determine molecular structure of promisin...new method, GRAND RAPIDS, Mich., Oct. 15 Researc...an Andel Institute (VAI) have,determined how the h...sely,binds to its receptor. This detailed structur... drugs for anxiety, depression, and related disord...
Other Medicine Technology:Landmark Study Demonstrates Potential of Radioimmunotherapy for Treatment of Indolent B-Cell Non-Hodgkin's Lymphoma 2Landmark Study Demonstrates Potential of Radioimmunotherapy for Treatment of Indolent B-Cell Non-Hodgkin's Lymphoma 3Landmark Study Demonstrates Potential of Radioimmunotherapy for Treatment of Indolent B-Cell Non-Hodgkin's Lymphoma 4Landmark Study Demonstrates Potential of Radioimmunotherapy for Treatment of Indolent B-Cell Non-Hodgkin's Lymphoma 5VAI Finding Could Lead to New Drugs for Anxiety, Depression 2
Stookey Cranial Rongeur
Lempert Rongeur
Miniflexoscopes
...atures an advanced design that accommodates both s...em gives surgeons the flexibility to easily custom...ty is built-in to every aspect of the Trinica syst...st anti-migration system to the screw options and ...
Medicine Products: